- Home
- CAPT vs ANTX Comparison
CAPT vs ANTX Comparison
Compare CAPT & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPT
- ANTX
- Stock Information
- Founded
- CAPT 2005
- ANTX 2017
- Country
- CAPT South Korea
- ANTX United States
- Employees
- CAPT N/A
- ANTX N/A
- Industry
- CAPT Blank Checks
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- CAPT Finance
- ANTX Health Care
- Exchange
- CAPT Nasdaq
- ANTX Nasdaq
- Market Cap
- CAPT 31.2M
- ANTX 34.4M
- IPO Year
- CAPT N/A
- ANTX 2022
- Fundamental
- Price
- CAPT $0.83
- ANTX $1.22
- Analyst Decision
- CAPT
- ANTX Buy
- Analyst Count
- CAPT 0
- ANTX 2
- Target Price
- CAPT N/A
- ANTX $2.00
- AVG Volume (30 Days)
- CAPT 154.6K
- ANTX 45.6K
- Earning Date
- CAPT 01-01-0001
- ANTX 11-12-2025
- Dividend Yield
- CAPT N/A
- ANTX N/A
- EPS Growth
- CAPT N/A
- ANTX N/A
- EPS
- CAPT N/A
- ANTX N/A
- Revenue
- CAPT $17,389,944.00
- ANTX N/A
- Revenue This Year
- CAPT N/A
- ANTX N/A
- Revenue Next Year
- CAPT N/A
- ANTX N/A
- P/E Ratio
- CAPT N/A
- ANTX N/A
- Revenue Growth
- CAPT 84.70
- ANTX N/A
- 52 Week Low
- CAPT $0.37
- ANTX $0.98
- 52 Week High
- CAPT $1.94
- ANTX $1.68
- Technical
- Relative Strength Index (RSI)
- CAPT 39.02
- ANTX 47.17
- Support Level
- CAPT $0.82
- ANTX $1.13
- Resistance Level
- CAPT $0.86
- ANTX $1.25
- Average True Range (ATR)
- CAPT 0.05
- ANTX 0.06
- MACD
- CAPT 0.00
- ANTX -0.01
- Stochastic Oscillator
- CAPT 10.25
- ANTX 37.46
About CAPT Captivision Inc.
Captivision Inc Formerly Glaam Co Ltd is engaged in manufacturing, installing, and selling LED display G-Glass. G-Glass is an integrated ICT product that has the basic characteristics of transparent glass but can display media images at the same time. It implements media images through the glass surface while preserving the features of clear and transparent glass. G-Glass is the world's first IT building material that can be applied to various places where glass is used.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.